Skip to content

Comparison of HFNO and FMV on Desaturations During Panendoscopy Under General Anesthesia

Comparison of High-flow Nasal Oxygen Therapy and Face Mask Ventilation on Desaturations During Panendoscopy Under General Anesthesia

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05593718
Enrollment
450
Registered
2022-10-25
Start date
2024-10-20
Completion date
2024-11-30
Last updated
2024-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ENT Tumor

Keywords

Panendoscopy, nasal high flow oxygen therapy, face mask ventilation, desaturation

Brief summary

Panendoscopy is a common procedure that requires deep and short anesthesia. The main challenge is the sharing of the airway between the anesthesia team and the surgical team. There are several methods to ensure oxygenation during this type of procedure: oro-tracheal intubation, jet ventilation, spontaneous ventilation anesthesia, apneic ventilation with intermittent face mask ventilation. There is no consensus regarding the best airway management technique for this procedure. Regardless of the method chosen to ensure oxygenation during this procedure, the risk of hypoxemia during desaturation episodes is significant. However, the use of HFNO seems to show a prolongation of apnea time without desaturations (\< 90% SpO2) and seems to allow the performance of panendocoscopies. In the Besançon University Hospital, since 2017, all panendoscopies are performed with HFNO. Before 2017, panendoscopies were performed under face mask ventilation. The main of the study hypothesis is that HFNO brought a gain in terms of safety, especially on the desaturation rate compared to face mask ventilation. The investigators will carry out a quasi-experimental study comparing two periods. The first period concerns the years 2015-2016. It aims to study patients who had panendoscopies performed under FMV. The second period covers the years 2018-2019. It aims to study patients who had panendoscopies performed under HFNO. The year 2017 is considered as the washout period necessary to avoid the learning effect of the HFNO introduced during that year.

Detailed description

Currently, there are several strategies to ensure oxygenation during this specific type of ENT management: * Mechanical ventilation with oro-tracheal intubation (OTI) * face mask ventilation (FMV) * Jet ventilation * HFNO Each of these methods has advantages and disadvantages, which explains why there are no clear recommendations to date on the preferred anesthesia and oxygenation technique. Regardless of the method chosen, the risks remain significant for the patient, particularly the risk of hypoxemia during a desaturation episode. In 2017, HFNO was introduced for panendoscopies in the Besançon University Hospital. Before 2017, panendoscopies were mainly perfomed with intermittent face mask ventilation. The objective of the study is to compare the FMV group (patients receiving panendoscopy and ventilated with FMV during 2015-2016) with the HFNO group (patients receiving panendoscopy and oxygenated with HFNO during 2018-2019) with respect to perprocedural hypoxemia (SpO2\<90% for more than 1 minute). Secondary objectives are to compare complications, use of oro-tracheal intubation, and procedure duration between the two oxygenation methods.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* major patients receiving panendoscopy * patients ventilated by face mask during the first period, * patients receiving oxygen by HFNO during the second period

Exclusion criteria

* Patients receiving ventilatory strategy other than those selected by time period. * Patients receiving panendoscopies performed with a method of oxygenation other than those defined in their period.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients with oxygen desaturationmore than 1 minute during the interventionProportion of patients with oxygen desaturation (SpO2 \< 90%) for more than 1 minute.

Secondary

MeasureTime frameDescription
Proportion of patients requiring repeat face mask ventilationmore than 1 minute during the interventionProportion of patients requiring repeat face mask ventilation (at least one reventilation outside the initial denitrogenation)
Proportion of patients requiring oro-tracheal intubationduring the intervention (max 6hours)from induction of anaesthesia to discharge from the operating theatreProportion of patients intubated during panendoscopy
Duration of the procedureduring the intervention (max 6hours) from induction of anaesthesia to discharge from the operating theatreTime (minutes) from induction of anaesthesia to discharge from the operating theatre
Incidence of mild intraoperative complicationsmore than 1 minute during the interventionComplications are : mild bradycardia (between 45 and 30 beats per minute), hypotension defined by MAP (between 65 and 40mmHg), hypercapnia (betaween 60 and 80 mmHg)
Incidence of major intraoperative complicationsmore than 1 minute during the interventionComplications are : Tracheotomy, extreme bradycardia \< 30 beats per minute, hemodynamic instability defined by MAP \< 40mmHg, hypercapnia (more than 80 mmHg)

Countries

France

Contacts

Primary ContactDavid Ferreira, MD, PhD
dferreira@chu-besancon.fr+33642841108

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026